chr4-5708392-G-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_147127.5(EVC2):​c.122C>A​(p.Pro41His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00463 in 1,496,282 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P41T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0028 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 22 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

2
2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: 0.448

Publications

2 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061277747).
BP6
Variant 4-5708392-G-T is Benign according to our data. Variant chr4-5708392-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 193503.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00281 (428/152100) while in subpopulation NFE AF = 0.00453 (308/67948). AF 95% confidence interval is 0.00412. There are 2 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.122C>Ap.Pro41His
missense
Exon 1 of 22NP_667338.3
EVC2
NM_001166136.2
c.-13+437C>A
intron
N/ANP_001159608.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.122C>Ap.Pro41His
missense
Exon 1 of 22ENSP00000342144.5
EVC2
ENST00000310917.6
TSL:1
c.-13+437C>A
intron
N/AENSP00000311683.2
EVC2
ENST00000475313.5
TSL:1
n.-13+437C>A
intron
N/AENSP00000431981.1

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
428
AN:
151984
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000821
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00453
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00361
AC:
331
AN:
91778
AF XY:
0.00352
show subpopulations
Gnomad AFR exome
AF:
0.000659
Gnomad AMR exome
AF:
0.00157
Gnomad ASJ exome
AF:
0.0179
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000588
Gnomad NFE exome
AF:
0.00522
Gnomad OTH exome
AF:
0.00426
GnomAD4 exome
AF:
0.00484
AC:
6506
AN:
1344182
Hom.:
22
Cov.:
30
AF XY:
0.00470
AC XY:
3115
AN XY:
662254
show subpopulations
African (AFR)
AF:
0.000698
AC:
19
AN:
27240
American (AMR)
AF:
0.00135
AC:
42
AN:
31036
Ashkenazi Jewish (ASJ)
AF:
0.0188
AC:
441
AN:
23408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31538
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74740
European-Finnish (FIN)
AF:
0.000660
AC:
22
AN:
33314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4482
European-Non Finnish (NFE)
AF:
0.00540
AC:
5733
AN:
1062352
Other (OTH)
AF:
0.00444
AC:
249
AN:
56072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
385
770
1154
1539
1924
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00281
AC:
428
AN:
152100
Hom.:
2
Cov.:
32
AF XY:
0.00248
AC XY:
184
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.000819
AC:
34
AN:
41532
American (AMR)
AF:
0.00131
AC:
20
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5104
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00453
AC:
308
AN:
67948
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00459
Hom.:
0
Bravo
AF:
0.00280
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00441
AC:
17
ExAC
AF:
0.00155
AC:
57

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
1
1
Ellis-van Creveld syndrome (2)
-
-
2
not specified (2)
-
-
1
Curry-Hall syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.018
T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.45
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.28
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.14
MVP
0.77
MPC
0.11
ClinPred
0.033
T
GERP RS
1.9
PromoterAI
0.013
Neutral
Varity_R
0.065
gMVP
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs544397395; hg19: chr4-5710119; COSMIC: COSV53832620; COSMIC: COSV53832620; API